It has been previously described that COLI and FN1 signaling through integrins promotes the expression of stem cell markers such as CD133, SOX2, and nestin and enhances glioma cell aggressiveness [11, 46, 47, 57]. The gene discussed is NES; the disease is central nervous system cancer.